To understand better the molecular and cellular events associated with status epilepticus, a multifaceted analysis has begun on hippocampal tissues therapeutically removed from patients with temporal lobe epilepsy. In this first study, quantitative changes in major ganglioside species are reported, as well as the immunocytochemical localization on the ganglioside GD3 in epileptic human hippocampus. Although significant variations were found between patients, the pattern of change was consistent when compared to normal values obtained from an autopsied specimen and the literature. Total ganglioside content was reduced in epileptic hippocampi, which was attributable, in part, to pyramidal cell loss found in CAl and CA3. In each case, the percentage of ganglioside GD3 was increased significantly, while ganglioside GD1. decreased. The former change is probably associated with reactive astrocytosis and the latter with loss of neuronal dendrites. Immunocytochemical localization revealed GD3 in the stratum radiatum and the subgranular layer of the dentate gyrus. In these areas, GD3 was present in punctate structures and astrocytes. These findings indicate that GD3 increases in selected areas of the sclerotic hippocampus and is presumably related to localized accumulation of reactive glial cells. Since gangliosides have a high affinity for calcium and localized increase in extracellular calcium could disrupt normal neuronal function, the localized increase in GD3 may not only denote reactive glial cells but may contribute directly to the altered, hyperexcitable condition of epilepsy.
INTRODUCTION
Epilepsy is a major debilitating disease of the central nervous system (CNS) which is characterized by synchronized neuronal discharges [1] . Despite intensive research efforts, the cellular and molecular basis of epilepsy remains uncertain. We have begun a multifaceted analysis of human hippocampal tissue obtained from patients with electrically characterized temporal lobe epilepsy. By determining the biochemical and morphological features that characterize human epileptic tissue, we hope to identify the key factors that are responsible for promoting the hyperexcitable state. One possible factor is the glycolipid components of cell membranes.
Gangliosides are a family of sialic acid-containing glycolipids that are enriched in neuronal membranes [2] [3] [4] . These molecules participate in numerous cellular phenom-tions in neural tissues. For example, GD3 is often found in high concentrations in traumatized CNS tissue and is considered a marker for reactive glia in many neurological diseases [10, 12, 14, 15, 16] . Hence, an examination of gangliosides can provide important information on the health and cellular composition of brain tissue.
Studies from our laboratory [17] [18] [19] and the laboratories of others [20, 21] have revealed significant ganglioside changes in various animal models of experimentally induced seizures. These changes reflect, to some extent, the pathological changes that are associated with epileptic brain. In humans as well as in animals, these pathological changes frequently involve neuronal loss and gliosis. In the hippocampus of an epileptic, this is referred to as "hippocampal sclerosis," which is characterized by gliosis and loss of neurons in the Sommer sector and end folium (Rose's area HI and H3-5) [22] [23] [24] [25] .
One principal aim of the present study was to examine changes in ganglioside GD3. We have previously shown that GD3 is closely associated with reactive, but not resting, glial cells [10, 16, 26, 27] . In addition, GD3 is associated with a number of cells, such as Muller glial cells [15] , undifferentiated neurons [14, 28] , and malignant transformed cells [29] , which share a common property in being metabolically active. We have hypothesized that the membranes of these cells must be highly permeable to ions and metabolites [10, 27] . Hence, reactive glial cells may have fundamental significance in regulating the extracellular environment in epileptogenesis [30] . To test this hypothesis, our first objective in this study was to test for the presence of GD3-positive glia and determine their tissue distribution. The availability of brain tissue from human patients offers a unique opportunity to correlate the biochemical and immunohistochemical changes in ganglioside distribution that are associated with electrophysiologically and clinically defined epileptic tissue.
MATERIALS AND METHODS Brain Tissues
Hippocampal gyri from epileptic patients were removed en bloc during surgery, and quickly cut into transverse slabs 1-2 cm wide. Individual specimens were either frozen on dry ice or fixed by immersion in 0.1 M phosphate buffer containing 2 percent formaldehyde. Frozen tissue slabs were used for both quantitative ganglioside analysis and immunocytochemical localization of GD3 on immediately adjacent tissue. Since histological preservation in fresh-frozen tissue is relatively poor, quickly fixed tissue was also examined by immunocytochemistry.
A normal control hippocampus was obtained with permission from a 26-year-old male who died suddenly with no known neurological symptoms. Comparable slabs of hippocampal tissue were obtained after autopsy and frozen on dry ice within 16 hours of death. Since gangliosides are relatively stable after death, the results of quantitative analysis were considered reliable. Immunocytochemical study was limited to freshfrozen tissue from the hippocampus and was used only for comparative localization.
Ganglioside Quantitation
The amount of major gangliosides within samples was determined by methods described in detail elsewhere [31] .. Briefly, a ganglioside-enriched fraction was obtained from each sample after chloroform/methanol extraction and DEAE column chromatography. Individual gangliosides were separated by thin-layer chromatography (TLC) [32] , visualized by resorcinol, and quantitated with a densitometer.
Immunocytochemical Localization
To correlate biochemical analysis with immunocytochemical localization, freshfrozen samples were first sectioned and the remaining adjacent tissue processed for ganglioside quantitation. Frozen specimens were sectioned on a cryotome (10 ,um), mounted on glass cover slips coated with poly-l-lysine, and allowed to air dry for one hour. Sections were fixed in 0.1 M phosphate buffered saline (PBS), containing 4 percent formaldehyde for five minutes, and rinsed with PBS containing 0.3 percent gelatin. All subsequent steps were performed in PBS with gelatin.
Monoclonal antibody R24 was provided by Dr. K.O. Lloyd, Sloan-Kettering Institute, New York, and has known specificity for GD3 [33] . Polyclonal rabbit antibody against purified human glial fibrillary acidic protein (GFAP) was provided and characterized by Dr. L.F. Eng, Stanford University, Palo Alto, California. These primary antibodies were diluted 1:75 for anti-GD3 and 1:300 for anti-GFAP and applied to sections for 20 minutes. After rinsing, sections were incubated for 20 minutes in peroxidase-conjugated secondary antibody. Anti-GD3 was localized with goat anti-mouse IgG (Sigma) diluted 1:40, and anti-GFAP was localized with goat anti-rabbit IgG (Cappel), diluted 1:300.
Formaldehyde-fixed tissues were postfixed by immersion in 5 percent acrolein in phosphate buffer (PB) for one hour and sectioned on a vibrotome (50 ,um). Sections were incubated in PB with 0.03 percent Triton-X100 for one hour, rinsed, and treated to block nonspecific stain. Sections were reacted at room temperature in the following reagents in PB at room temperature and rinsed after each step: 1 percent borohydride for ten minutes, 0.2 percent lysine and 0.1 percent gelatin for one hour, and 4 percent goat serum for 2-24 hours. Sections were incubated for 48 hours at 40C with anti-GD3 diluted 1:200 or anti-GFAP diluted 1:600. After rinsing, sections were incubated for 48 hours with the complementary secondary antibodies diluted threefold more than for frozen cryotome sections. Peroxidase activity was visualized with diaminobenzidine/ H202.
The quantitative ganglioside analysis and immunocytochemical studies were performed and evaluated independently in order to prevent bias.
RESULTS

Ganglioside Quantitation
The study was divided into two phases. In the initial phase, full transverse slabs of fresh-frozen tissue containing the entire hippocampal formation were assayed for ganglioside distribution. Four specimens from epileptic patients were assayed. The pattern of gangliosides separated on a TLC plate and treated with resorcinol is shown in Fig. 1 . Quantitative results shown in Table 1 reveal significant differences between patients in the percentage of GD3.
Immunocytochemical localization of GD3 in adjacent sections showed corresponding qualitative differences in the intensity of stain between specimens. The cell loss was apparent in the prosubiculum, and no stain was detected above background.
Based on these findings, hippocampal specimens from a second set of patients were prepared for ganglioside quantitation. As shown in Fig. 2 , the CA1 region was dissected into two approximately equal areas. The area designated "A" coincides with the region associated with the most common pyramidal cell loss (Sommer's sector). The area designated "B" was immediately adjacent and may include part of the prosubiculum where neuronal loss was less pronounced. Hippocampi from two patients and one normal autopsy were thus analyzed, and the results are shown in Table 2 . The most striking differences were in the percentages of GD3. In A and B regions from the normal control, GD3 was 2.9 percent. By comparison, GD3 was significantly higher in region A than region B in the two patients. This difference corresponds to the location of the pyramidal cell loss which was distinct in region A of both patients, but not apparent in region B.
In addition to GD3, other consistent changes were evident in the ganglioside content GM, appeared to decrease moderately. The percentages of GD2, GDMb, and GT1b were moderately elevated. Total ganglioside content within the tissue was markedly decreased in epileptic tissues. Most of these changes were noticeably evident in comparing sub-regions A and B from the two epileptic patients.
Immunocytochemical Localization
Based on immunocytochemical study of all patients' and control tissues, the distribution of GD3 associated with epilepsy was determined at the light microscopic level. In sections of patients' hippocampi, the overall intensity of GD3 immunoperoxidase stain varied from indistinct background levels to heavy localized deposits of reactivity. These qualitative variations correlated directly with the quantitative difference in GD3 levels determined by biochemical assay. No distinct stain was evident in hippocampus from normal tissue, and only moderate stain was present in sections Gangliosides shown as percentage of total for each sample. Location of regions "A" and "B" are illustrated in Fig. 2 from patients with low levels of GD3 increase. In cases of major increases of GD3, a distinct and characteristic immunostaining pattern was evident. Since the immunocytochemical localization and quantitative analyses were performed independently with blind controls, these results indicated that the immunocytochemical localization method reliably reflects the changes in GD3 associated with the epileptic tissue.
Whether the endogenous GD3 present in normal hippocampus may be masked to immunodetection or distributed relatively uniformly was not determined. Despite the variation in stain intensity, a consistent pattern of localization was observed. In most cases, dense immunoperoxidase stain was localized in the subgranular layer (SGL) of the dentate and in parts of the stratum radiatum (SR) (Figs. 3 and  4) . Lighter stain was apparent in adjacent regions of the stratum moleculare (SM). Within these regions, immunodetectable GD3 appeared in small, broadly scattered, punctate structures and in stellate cells that were identified by location, shape, and size as astrocytes (Fig. 5) Astrocytes stained by anti-GFAP were found throughout normal hippocampal tissue in patterns distinct for each area. For example, stellate astrocytes were located in the stratum moleculare (Fig. 6D) . Within the dentate layer, cell bodies of large astrocytes were located in the subgranular layer, and many of their processes extended into the granule cell layer. In areas of neuronal loss, a massive increase in GFAPpositive processes was found (Fig. 6) . The dense matrix of astrocytic processes in these sclerotic areas obscured the identification and morphology of individual astrocytes. Areas of astrocyte proliferation coincided in large part with the distribution of GD3 associated with epilepsy (Fig. 6) . DISCUSSION The present study shows that increased levels of GD3 are present within localized regions of the hippocampal formation of epileptic patients. The amount of GD3 varied widely between patients and is correlated in part with the degree of pyramidal cell death. Immunocytochemically detectable GD3 is seen in dispersed punctate structures and associated with astrocytes. These findings support previous studies which indicate that GD3 is associated with neural degeneration and accompanying gliosis [28] .
One important question is whether the localized increase of GD3 is a consequence or, rather, a causative factor of epilepsy. It is known that GD3, as a divalent anionic glycolipid, binds calcium with high affinity [34, 35] . An Other questions arising from this study include the ultrastructural distribution of GD3 in normal and epileptic hippocampi. If GD3 is involved in promoting neuronal hyperexcitability, then it should be distributed in association with neuronal membranes. The GD3-positive punctate structures in epileptic tissue are similar in size to focal synapses and may represent astrocytic processes covering junctional contacts.
Also unknown is the distribution of GD3 in the normal hippocampus. In the normal human hippocampus assayed, GD3 was 2.9 percent of the gangliosides. Despite this C. . substantial level of GD3 in normal tissue, immunocytochemical localization revealed no distinct stain above background. Similarly, other immunocytochemical studies of GD3 localization have been unable to show distinct localization in the adult brain of mice, despite its known biochemical presence [28, 36] . GD3 has been shown to accumulate in the plasma membrane of oligodendrocytes during development [37] . Perhaps endogenous GD3 in normal adult tissue is masked from immunodetection. The majority of immunodetectable GD3 associated with epilepsy was localized in two zones: the stratum radiatum of CAI, and the subgranular layer of the dentate. Neuronal death accompanying epilepsy is most common in CA1 and was clearly associated with increased levels of GD3 in this region. However, in most cases of epilepsy, relatively little neuronal death is found in the dentate granule cell layer or in CA4, which border the subgranular layer [22] [23] [24] [25] . And yet, without substantial local neuronal death, the subgranular layer had increased levels of GD3. Thus, GD3 accumulation within the hippocampus of epileptics may signify more than simply the presence of reactive astrocytes in zones of neuronal degeneration.
It is tempting to suggest that many forms of epilepsy are caused by an initial trauma leading to the generation of reactive astrocytes and accumulation of GD3. The high affinity of GD3 for calcium results in excessive calcium-dependent neural activities, which may include increases in transmitter release and protein phosphorylation. A cycle of neuronal hyperactivity and death followed by proliferation of GD3-positive reactive glia may perpetuate the cycle.
Although speculative, this scheme is consistent with several lines of morphological and physiological evidence regarding temporal lobe epilepsy. Special attention is directed to the subgranular layer of the dentate where GD3 increases have been found in both epileptic human and kindled cat hippocampi. The dentate granule cells supply a major excitatory input into the hippocampus, the Schaffer collaterals, which have long been considered a primary candidate in promoting hippocampal hyperexcitability [38] . A dense layer of astrocytic cell bodies is present in the subgranular layer, and many of their processes are in close proximity to granule cell bodies and axons [39, 40] . It is known that the principal neural transmitter of granule cells is glutamate, and that pharmacological agents which block glutamate activity inhibit ictal activity [41, 42] . In addition, the injection of glutamate has been shown to cause neuronal death and gliosis, which is typical of epileptic hippocampal sclerosis [43] . Calcium has been implicated in epileptogenesis [44, 45] , and certain anticonvulsant drugs inhibit calcium-dependent protein phosphorylation [46] . Notably, Ca/calmodulin-dependent protein kinase is localized preferentially in the hippocampus and appears particularly abundant in the dentate [47] . In vitro experiments have shown that gangliosides can enhance Ca++/calmodulin protein phosphorylation [48] . In conjunction with this process, long-term changes occur in Ca++/calmodulin phosphorylation activity of kindled rat hippocampi [49] . The present results support this scheme, although other interpretations are possible. Future experiments, such as localized injections of GD3, are planned to test the proposed GD3 mechanisms of epilepsy directly.
